Leadership & Pay ·
Precision BioSciences, Inc. announced several senior leadership changes effective August 1, 2026, including the…
DTILPrecision Biosciences Inc
Precision BioSciences, Inc. announced several senior leadership changes effective August 1, 2026, including the promotion of Alex Kelly from Chief Financial Officer to Chief Operating Officer and the appointment of Naresh Tanna as Chief Financial Officer. Additionally, Mei Burris was designated as Chief Accounting Officer and principal accounting officer. The company is a clinical-stage gene editing company developing in vivo gene editing therapies for high unmet need diseases.